Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Mar 29, 2016

Sanofi Pasteur Collaboration Uses Novel Technology towards Development of a 2nd Generation Influenza Vaccine

Pre-clinical immunogenicity and efficacy data published in Journal of Virology
Mar 16, 2016

Sanofi and Regeneron Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal
Mar 11, 2016

Sanofi and Regeneron Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis
Mar 4, 2016

Sanofi and Regeneron Announce Humana Provides Exclusive or Preferred Access to Praluent® (alirocumab) Injection on Their Commercial and Medicare Formularies

Praluent is now covered by most health insurance and Medicare plans
Feb 23, 2016

Sanofi US to Return Auvi-Q® (epinephrine injection, USP) Rights to kaléo
- Photos 1

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.